Lesley Ann Calhoun

Officer, Global Blood Therapeutics, Inc.

Companies

Aligos Therapeutics, Inc.Officer Mar 4, 2025 to now¹
Tango Therapeutics (United States)Board member Aug 12, 2021 to now²
Aligos Therapeutics, Inc.Chief financial officer Oct 15, 2020 to Oct 15, 2020³
Global Blood Therapeutics, Inc.Officer Feb 13, 2018 to May 28, 2020⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Tango Therapeutics (United States) TNGX16,500 shares⁵$391.7K at $23.74Jun 5, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 5, 2026Granted 4,000 shares of Tango Therapeutics (United States)⁵
Jun 5, 2025Granted 6,250 shares of Tango Therapeutics (United States)⁶
Jun 5, 2024Sold 5,000 shares at $7.21 of Tango Therapeutics (United States)⁷
Jun 5, 2024Granted 6,250 shares of Tango Therapeutics (United States)⁷
Jun 6, 2023Granted 5,000 shares of Tango Therapeutics (United States)⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAligos Therapeutics, Inc., Officer
2
SEC EDGARTango Therapeutics (United States), Board member
3
SEC EDGARAligos Therapeutics, Inc., Chief financial officer
4
SEC EDGARGlobal Blood Therapeutics, Inc., Officer
5
SEC EDGARTango Therapeutics (United States) shares after the filing of Jun 5, 2026
6
SEC EDGARForm 4 filed Jun 9, 2025
7
SEC EDGARForm 4 filed Jun 7, 2024
8
SEC EDGARForm 4 filed Jun 8, 2023